Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1099)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$532.13
Total Value
$191.57K
Shares Held After
9,270
% of Holdings
3.7%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance & CAO
Shares
2,500
Price
$58.59
Total Value
$146.48K
Shares Held After
30,867
% of Holdings
7.5%
Korro Bio, Inc. (KRRO)
BASKETT FOREST — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
Chang Carmen — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
Florence Anthony A. Jr. — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
Yang Rick — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
New Enterprise Associates 17, L.P. — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
SANDELL SCOTT D — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
Mathers Edward T — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
1,000
Price
$2.65
Total Value
$2.65K
Shares Held After
106,465
% of Holdings
0.9%
REGENXBIO Inc. (RGNX)
PAKOLA STEVE — Chief Medical Officer
Shares
5,124
Price
$10.35
Total Value
$53.03K
Shares Held After
247,926
% of Holdings
2.0%
Annexon, Inc. (ANNX)
Carson William H. — Director
Shares
8,000
Price
$5.67
Total Value
$45.36K
Shares Held After
62,405
% of Holdings
12.8%
PTC THERAPEUTICS, INC. (PTCT)
Okey Stephanie — Director
Shares
14,000
Price
$70.00
Total Value
$980.00K
Shares Held After
8,000
% of Holdings
63.6%
PTC THERAPEUTICS, INC. (PTCT)
Okey Stephanie — Director
Shares
1,167
Price
$70.00
Total Value
$81.69K
Shares Held After
8,000
% of Holdings
12.7%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
348
Price
$51.02
Total Value
$17.75K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
29,652
Price
$50.45
Total Value
$1.50M
Shares Held After
348
% of Holdings
98.8%
Stoke Therapeutics, Inc. (STOK)
Krainer Adrian R. — Director
Shares
33,243
Price
$39.74
Total Value
$1.32M
Shares Held After
283,302
% of Holdings
10.5%
Stoke Therapeutics, Inc. (STOK)
TZIANABOS ARTHUR — Director
Shares
4,355
Price
$40.00
Total Value
$174.21K
Shares Held After
31,339
% of Holdings
12.2%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
8,671
Price
$72.00
Total Value
$624.31K
Shares Held After
7,465
% of Holdings
53.7%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$22.12
Total Value
$22.12K
Shares Held After
37,415
% of Holdings
2.7%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
2,300
Price
$9.21
Total Value
$21.18K
Shares Held After
67,419
% of Holdings
3.3%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
2,299
Price
$8.93
Total Value
$20.53K
Shares Held After
69,719
% of Holdings
3.2%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
2,531
Price
$9.21
Total Value
$23.31K
Shares Held After
69,796
% of Holdings
3.5%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
2,530
Price
$8.93
Total Value
$22.59K
Shares Held After
72,327
% of Holdings
3.4%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
281,858
Price
$19.80
Total Value
$5.58M
Shares Held After
4,774,058
% of Holdings
5.6%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
219,758
Price
$19.32
Total Value
$4.25M
Shares Held After
5,055,916
% of Holdings
4.2%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
9,482
Price
$18.21
Total Value
$172.69K
Shares Held After
5,275,674
% of Holdings
0.2%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
17,591
Price
$76.34
Total Value
$1.34M
Shares Held After
242,662
% of Holdings
6.8%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
16,512
Price
$75.47
Total Value
$1.25M
Shares Held After
260,253
% of Holdings
6.0%
Entrada Therapeutics, Inc. (TRDA)
WENTWORTH KORY JAMES — Chief Financial Officer
Shares
11,388
Price
$13.02
Total Value
$148.22K
Shares Held After
121,510
% of Holdings
8.6%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
10,129
Price
$30.19
Total Value
$305.83K
Shares Held After
25,000
% of Holdings
28.8%
IONIS PHARMACEUTICALS INC (IONS)
Jenne Kyle — EVP, Chf GL Pdt Str Ofcr
Shares
16,086
Price
$76.30
Total Value
$1.23M
Shares Held After
11,714
% of Holdings
57.9%
IONIS PHARMACEUTICALS INC (IONS)
Jenne Kyle — EVP, Chf GL Pdt Str Ofcr
Shares
21,191
Price
$75.50
Total Value
$1.60M
Shares Held After
27,800
% of Holdings
43.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$548.10
Total Value
$65.77K
Shares Held After
130
% of Holdings
48.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$547.14
Total Value
$218.86K
Shares Held After
250
% of Holdings
61.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$546.21
Total Value
$262.18K
Shares Held After
650
% of Holdings
42.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
936
Price
$545.05
Total Value
$510.17K
Shares Held After
1,130
% of Holdings
45.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
824
Price
$544.04
Total Value
$448.29K
Shares Held After
2,066
% of Holdings
28.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$542.88
Total Value
$304.01K
Shares Held After
2,890
% of Holdings
16.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$541.69
Total Value
$216.68K
Shares Held After
3,450
% of Holdings
10.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$540.63
Total Value
$237.88K
Shares Held After
3,850
% of Holdings
10.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,351
Price
$539.84
Total Value
$729.32K
Shares Held After
4,290
% of Holdings
23.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
563
Price
$539.02
Total Value
$303.47K
Shares Held After
5,641
% of Holdings
9.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
647
Price
$537.92
Total Value
$348.04K
Shares Held After
6,204
% of Holdings
9.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
459
Price
$535.99
Total Value
$246.02K
Shares Held After
6,851
% of Holdings
6.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,320
Price
$535.09
Total Value
$706.32K
Shares Held After
7,310
% of Holdings
15.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$533.23
Total Value
$21.33K
Shares Held After
8,630
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$531.54
Total Value
$21.26K
Shares Held After
8,670
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$530.49
Total Value
$63.66K
Shares Held After
8,710
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$530.03
Total Value
$424.02K
Shares Held After
8,830
% of Holdings
8.3%
Showing 351–400 of 1099 transactions (page 8 of 22)